The Global CEO Initiative on Alzheimer's Disease
Budget
€500 — €0
EP Access
0
accredited persons
Staff
10
6 FTE
EU Grants
None
Mission & Goals
The Global CEO Initiative on Alzheimer’s Disease (CEOi), founded in 2013, is an organization of private-sector leaders who have joined together to provide business leadership in the fight against Alzheimer’s. The CEOi believes that, during this era of aging populations, it will take visionary, coordinated, goal-oriented leadership of public and private leaders working together to solve our greatest challenges. It is convened by UsAgainstAlzheimer’s. Members consist of public and private healthcare organizations invested in healthy aging, brain health, and Alzhiemer's Disease research, policy and advocacy.
EU Legislative Interests
Institute for Healthcare Improvement Healthier Together - EU NCD Initiative EU4Health Horizon Europe EU Cohesion Policy NextGenerationEU: Recovery and Resilience Facility European Green Deal European Digital Strategy Pharmaceutical Strategy for Europe
Communication Activities
• We have developed and published thought pieces on accelerated approval in US and how this informs strategies in Europe as it relates to Alzheimer's and brain health. • Support and engage in Alzheimer's and brain health advocacy activities across Europe including partnership with World Economic Forum, OECED, Alzheimer's International and European Brain Council • Convene global Alzheimer's research and policy conference, Lausanne Workshop. This is convened by Alzheimer's Disease International, OECD, and the World Economic Forum. To identify unmet solutions in brain health, aging, and Alzheimer's research and care. • Ongoing collaboration with the World Health Organization on their dementia policy plan Host round table series on areas of research and innovation in brain health and Alzheimer's with speakers from industry, policy, and advocacy organizations.
Interests Represented
Promotes their own interests or the collective interests of their members
Member Of
UsAgainstAlzheimer's: https://www.usagainstalzheimers.org/ American Academy of Neurology Industry Roundtable Member
Organisation Members
Janssen: https://www.janssen.com/ Eli Lilly: https://www.lilly.com/ AbbVie: https://www.abbvie.com/ Bank of America: https://www.bankofamerica.com/ Roche: https://www.roche.com/ Prothena: https://www.prothena.com/ World Health Organization: https://www.who.int/ AC Immune: https://www.acimmune.com/ World Economic Forum: https://www.weforum.org/?_gl=1*16m65do*_up*MQ..&gclid=CjwKCAiAnZCdBhBmEiwA8nDQxcHAGAsn36ShZkmup-bkBmgxeEzSN8av6Y5iNmkRp-Qr4FFlDqy40hoCq0wQAvD_BwE Global Alzheimer's Platform Foundation: https://globalalzplatform.org/ UnitedHealthcare: https://www.uhc.com/ Otsuka: https://www.otsuka-us.com/ Neurovision: https://neurovision.com/ OECD: https://www.oecd.org/unitedstates/ Biogen: https://www.biogen.com/home.html Home Instead: https://www.homeinstead.com/ppc/dual/home-instead-senior-care/ Alzheimer's Disease International: https://www.alzint.org/ Eisai: https://www.eisai.com/index.html Cognito Therapeutics: https://cognitotx.com/ Merck: https://www.merck.com/ C2N: https://c2n.com/ Altoida: https://altoida.com/ Progressive Medical Research: https://www.progressivemedicalresearch.com/ Novo Nordisk: https://www.novonordisk.com/ Beckman Coulter:https://www.beckman.com/?utm_medium=cpc&utm_source=google&utm_campaign=cmna-corp-brand-20-06-ppc&utm_term=corp_leadgen_top&gclid=Cj0KCQiAx9q6BhCDARIsACwUxu75rPh4ujNzbNTh7_kkPO5igsbl0f_umXRDx5Kt_pJuB4ko8XnlI3IaAjjUEALw_wcB Quest: https://www.questdiagnostics.com/ Quanterix: https://www.quanterix.com/
Additional Information
N/A
Commissioner Meetings
No recorded meetings with EU commissioners.